Home
Vegard Tuseth's picture

Vegard Tuseth

Associate Professor
  • E-mailvegard.tuseth@uib.no
  • Phone+47 55 58 61 48
  • Visitor Address
    Armauer Hansens hus, Haukelandsveien 28
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Show author(s) (2022). Thrombus characteristics evaluated by acute optical coherence tomography in ST elevation myocardial Infarction. PLOS ONE. 12 pages.
  • Show author(s) (2022). Effects of add-on left ventricular assist device to extracorporeal membrane oxygenation during refractory cardiac arrest in a porcine model. ASAIO journal (1992). 531-540.
  • Show author(s) (2022). Effect of an optimized X-ray blanket design on operator radiation dose in cardiac catheterization based on real-world angiography. PLOS ONE.
  • Show author(s) (2020). Balanced biventricular assist versus extracorporeal membrane oxygenation in cardiac arrest. ASAIO journal (1992). 1110-1119.
  • Show author(s) (2019). Impella use in acute myocardial infarction complicated by cardiogenic shock and cardiac arrest: Analysis of 10 years registry data. Resuscitation. 178-184.
  • Show author(s) (2018). Left Versus Biventricular Assist Devices in Cardiac Arrest. ASAIO journal (1992). 489-496.
  • Show author(s) (2017). Administration of the Mitochondrial Permeability Transition Pore Inhibitor, TRO40303, prior to Primary Percutaneous Coronary Intervention, Does Not Affect the Levels of Pro-Inflammatory Cytokines or Acute-Phase Proteins. Cardiology. 122-132.
  • Show author(s) (2015). Effect of intravenous TRO40303 as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: MITOCARE study results. European Heart Journal. 112-119.
  • Show author(s) (2012). Rationale and Design of the 'MITOCARE' Study: A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of TRO40303 for the Reduction of Reperfusion Injury in Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction. Cardiology. 201-207.
  • Show author(s) (2011). Percutaneous catheter-based intracoronary infusion of insulin - a dose finding study in the porcine model. Basic & Clinical Pharmacology & Toxicology. 414-420.
  • Show author(s) (2010). Treatment of cardiogenic shock with left ventricular assist device combined with cardiac resynchronization therapy: A case report. Journal of Cardiothoracic Surgery.
  • Show author(s) (2010). Rationale and design of EXPLORE: a randomized, prospective, multicenter trial investigating the impact of recanalization of a chronic total occlusion on left ventricular function in patients after primary percutaneous coronary intervention for acute ST-elevation myocardial infarction. Trials. 9 pages.
  • Show author(s) (2010). Randomised comparison of percutaneous left ventricular assist device with open-chest cardiac massage and with surgical assist device during ischaemic cardiac arrest. Resuscitation. 1566-1570.
Academic lecture
  • Show author(s) (2021). Is the combined use of Impella┬« and VA-ECMO better than ECMO alone in refractory cardiogenicshock?
Letter to the editor
  • Show author(s) (2016). Experience from a randomized controlled trial with Impella 2.5 versus IABP in STEMI patients with cardiogenic pre-shock. Lessons learned from the IMPRESS in STEMI trial. International Journal of Cardiology. 894-896.
Doctoral dissertation
  • Show author(s) (2022). Mechanical assist in cardiac arrest: Optimising circulatory support. Experimental Studies.
Abstract
  • Show author(s) (2020). Is combined use of Impella┬« and VA-ECMO better than VA-ECMO alonein refractory cardiogenic shock? Perfusion.
  • Show author(s) (2019). Balanced biventricular assist versus extracorporeal membrane oxygenation in cardiac arrest. Journal of the American College of Cardiology. B794-B794.
Academic literature review
  • Show author(s) (2020). Temporal trends in X-ray exposure during coronary angiography and percutaneous coronary intervention. Journal of interventional cardiology. 1-9.

More information in national current research information system (CRIStin)